Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin

作者: Rodrigo E. Mendes , David J. Farrell , Robert K. Flamm , Helio S. Sader , Ronald N. Jones

DOI: 10.1128/JCM.00611-15

关键词:

摘要: Scattergrams between vancomycin and telavancin demonstrated susceptibility agreement rates of 99.96, 99.65, 100.00% for Staphylococcus aureus, Enterococcus faecalis, streptococci, respectively. A single very major error was obtained against E. while vancomycin-intermediate S. aureus (VISA) vancomycin-resistant teicoplanin-susceptible (VanB phenotype) faecalis were responsible minor errors. These results support the use to infer among indicated pathogens, except VISA, which should be tested susceptibility.

参考文章(5)
William J. Novick, Development of in vitro susceptibility testing criteria and quality control parameters Clinical Microbiology Newsletter. ,vol. 11, pp. 60- 62 ,(1989) , 10.1016/0196-4399(89)90068-8
Rodrigo E. Mendes, David J. Farrell, Helio S. Sader, Robert K. Flamm, Ronald N. Jones, Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 702- 706 ,(2015) , 10.1128/AAC.04052-14
Rodrigo E. Mendes, David J. Farrell, Helio S. Sader, Jennifer M. Streit, Ronald N. Jones, Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method Diagnostic Microbiology and Infectious Disease. ,vol. 81, pp. 275- 279 ,(2015) , 10.1016/J.DIAGMICROBIO.2014.12.011
Usa Pennsylvania, Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing TwentySecond Informational Supplement 7071 CLSI Wayne. ,vol. 33, ,(2013)